ListedSMEPharmaceuticals & DrugsGOLDLINE
Goldline Pharmaceutical IPO
Goldline Pharmaceutical IPO is an SME IPO raising ₹12 Cr at ₹41 – ₹43 a share. It listed on 19 May 2026 at ₹60, +39.0% against its issue price of ₹43, and trades at ₹37 today (−15.1% since issue). It was subscribed 597× in total.
₹43
Issue price
₹37
Price now
−15.1%
Since issue price
19 May 2026
Listed on
597×Subscribed (final) · all exchanges
597.4 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
We hold no bidding data for this issue
We could not retrieve a category split for this issue. It may have listed only on BSE — our category data comes from NSE, which is blind to BSE-only issues — or the exchange may no longer serve its bidding archive.
Category split (QIB / non-institutional / retail)not held
Price-point demand curvenot held
Total subscription figureheld